A novel approach to a patient with Crohn disease and a high stoma output: a missed opportunity?
The development of stricturing or penetrating behaviour in Crohn disease is influenced by disease location, clinical activity of the disease and smoking habit. The management of inflammatory bowel disease remains unsatisfactory, and the influence of current therapies--immunosuppressants, and especially the novel biological treatment now commonly used in Crohn disease--remains largely unknown. A relatively smaller number of patients receive dietary treatment as well. Physicians' scepticism, under-resourced dietetic departments and patient compliance are the main concerns in considering enteral nutrition. The management of high stomal output in Crohn disease is even more challenging. We report a case of active Crohn disease with high stoma output treated successfully solely with enteral feeding without the need for surgical intervention or administration of potent pharmacotherapy.
Jones
S
S
Dept. of Nutrition and Dietetics, Royal Gwent Hospital, Newport, South Wales, UK. Sian.Jones2@gwent.wales.nhs.uk
Shannon
H
H
Srivastava
E
E
Haboubi
N
N
D000328:Adult; D002364:Caseins / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D003125:Colostomy; D003424:Crohn Disease / Q000378:metabolism* / Q000628:therapy*; D004750:Enteral Nutrition; D005260:Female; D006801:Humans; D054047:Surgical Stomas
D002364:Caseins; D002614:Chelating Agents